In 2022, the import value of biopharmaceuticals into South Korea amounted to around 2.6 billion U.S. dollars. This is a roughly 27 percent decrease compared to the previous year. Imports of biopharmaceuticals have been growing steadily over the past several years, with 2021 having the highest import value over this period.
Value of biopharmaceuticals imported into South Korea from 2012 to 2022 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Pharmaceutical industry in South Korea
Overview
5
- Premium Statistic Pharmaceutical market: worldwide revenue 2001-2023
- Premium Statistic Pharmaceuticals market size South Korea 2012-2022
- Basic Statistic Pharmaceutical spending as share of GDP South Korea 2000-2022
- Basic Statistic Pharmaceutical spending per capita in South Korea 2000-2022
- Premium Statistic Number of pharmaceutical manufacturers South Korea 2012-2022
Production and distribution
6
- Basic Statistic Pharmaceutical production value South Korea 2012-2022
- Premium Statistic OTC drug products production value South Korea 2012-2022
- Premium Statistic Prescription drug products production value South Korea 2012-2022
- Premium Statistic Leading pharmaceutical products South Korea 2022, by production value
- Premium Statistic Number of pharmaceutical distributors South Korea 2012-2022
- Premium Statistic Number of pharmaceutical distributors South Korea 2022, by type
International trade
6
- Premium Statistic Pharmaceutical export value from South Korea 2012-2022
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2022, by export value
- Premium Statistic Biopharmaceuticals export value from South Korea 2012-2022
- Premium Statistic Pharmaceutical import value in South Korea 2012-2022
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2022, by import value
- Premium Statistic Biopharmaceutical import value in South Korea 2012-2022
Key players
6
- Premium Statistic Leading pharmaceutical businesses South Korea 2022, by revenue
- Premium Statistic Sales revenue Yuhan 2015-2022
- Premium Statistic Sales revenue of GC Pharma 2015-2023
- Premium Statistic Revenue of Chong Kun Dang 2015-2022
- Premium Statistic Sales revenue Kwang Dong Pharmaceutical 2011-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
OTC pharmaceuticals
5
- Premium Statistic Types of pharmaceutical drugs produced in South Korea 2022, by production value
- Premium Statistic Annual production value of OTC drugs in South Korea 2011-2022
- Premium Statistic Annual import value of OTC drugs in South Korea 2011-2022
- Premium Statistic Types of pharmaceutical drugs imported into South Korea 2022, by import value share
- Premium Statistic Amount of medication supplied to medical facilities South Korea 2022, by supply value
Further related statistics
20
- Biopharmaceutical production value in South Korea 2012-2022
- Biopharmaceutical market size in South Korea 2012-2022
- Global chemical drug and biologics market size 2014-2023
- Biopharmaceutical industry employee number by subsector U.S. 2020
- Biopharma global sales forecast by chain type 2016-2022
- Global biopharma spending on cold chain transport by mode 2018
- Employees in U.S. biopharmaceutical industry by occupational share 2020
- Bioreactors revenue in Latin America 2022-2027
- Global biopharma logistics spending forecast by chain type 2016-2022
- Number of biopharma venture financing deals 2017-2022
- Global biopharma spending on transport and packaging 2018
- Forecast: operating revenue biopharmaceutical manufacture China 2008-2020
- Secondary investments among biopharma companies 2018
- AI market size in global biopharma industry in 2018 and 2025, by region
- Investments in capabilities among life sciences companies 2018
- CAGR of regional biopharma AI markets globally 2018-2025
- Margin trend in biopharmaceutical industry worldwide 2002-2015
- Orphan and non-orphan drugs in the pipeline worldwide 2021
- Global AI market share in biopharma industry 2018, by region
- Share of biopharmaceutical employees in the UK in 2019, by region
Further Content: You might find this interesting as well
Statistics
- Biopharmaceutical production value in South Korea 2012-2022
- Biopharmaceutical market size in South Korea 2012-2022
- Global chemical drug and biologics market size 2014-2023
- Biopharmaceutical industry employee number by subsector U.S. 2020
- Biopharma global sales forecast by chain type 2016-2022
- Global biopharma spending on cold chain transport by mode 2018
- Employees in U.S. biopharmaceutical industry by occupational share 2020
- Bioreactors revenue in Latin America 2022-2027
- Global biopharma logistics spending forecast by chain type 2016-2022
- Number of biopharma venture financing deals 2017-2022
- Global biopharma spending on transport and packaging 2018
- Forecast: operating revenue biopharmaceutical manufacture China 2008-2020
- Secondary investments among biopharma companies 2018
- AI market size in global biopharma industry in 2018 and 2025, by region
- Investments in capabilities among life sciences companies 2018
- CAGR of regional biopharma AI markets globally 2018-2025
- Margin trend in biopharmaceutical industry worldwide 2002-2015
- Orphan and non-orphan drugs in the pipeline worldwide 2021
- Global AI market share in biopharma industry 2018, by region
- Share of biopharmaceutical employees in the UK in 2019, by region
MFDS (South Korea). (December 28, 2023). Value of biopharmaceuticals imported into South Korea from 2012 to 2022 (in million U.S. dollars) [Graph]. In Statista. Retrieved April 29, 2024, from https://www.statista.com/statistics/780914/south-korea-biopharmaceutical-import-value/
MFDS (South Korea). "Value of biopharmaceuticals imported into South Korea from 2012 to 2022 (in million U.S. dollars)." Chart. December 28, 2023. Statista. Accessed April 29, 2024. https://www.statista.com/statistics/780914/south-korea-biopharmaceutical-import-value/
MFDS (South Korea). (2023). Value of biopharmaceuticals imported into South Korea from 2012 to 2022 (in million U.S. dollars). Statista. Statista Inc.. Accessed: April 29, 2024. https://www.statista.com/statistics/780914/south-korea-biopharmaceutical-import-value/
MFDS (South Korea). "Value of Biopharmaceuticals Imported into South Korea from 2012 to 2022 (in Million U.S. Dollars)." Statista, Statista Inc., 28 Dec 2023, https://www.statista.com/statistics/780914/south-korea-biopharmaceutical-import-value/
MFDS (South Korea), Value of biopharmaceuticals imported into South Korea from 2012 to 2022 (in million U.S. dollars) Statista, https://www.statista.com/statistics/780914/south-korea-biopharmaceutical-import-value/ (last visited April 29, 2024)
Value of biopharmaceuticals imported into South Korea from 2012 to 2022 (in million U.S. dollars) [Graph], MFDS (South Korea), December 28, 2023. [Online]. Available: https://www.statista.com/statistics/780914/south-korea-biopharmaceutical-import-value/